Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin®)-induced intra-hepatic cholestasis: Report of two cases

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 3, 2000, Pages 365-368

  Katsinelos, Panagiotis ^a   Vasiliadis, Themistoklis ^a   Xiarchos, Panagiotis ^a   Patakiouta, Frida ^b   Christodoulou, Kiriakos ^a   Pilpilidis, Ioannis ^a   Eugenidis, Nikos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Amoxycillin clavulanate potassium; Intra hepatic cholestasis; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; URSODEOXYCHOLIC ACID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; JAUNDICE; LIVER BIOPSY; MALAISE; MALE; PRIORITY JOURNAL; PRURITUS;

EID: 0034082733     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012030-00017     Document Type: Article

References (33)

1. 1 Iravani A, Richard GA. Amoxycillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora. Antimicrob Agents Chemother 1986; 29:107-111.
2. 2 Augmentin jaundice. Aust Adverse Drug Reactions Bull November 1990.
3. 3 Michielsen PP, Van Outrijve MJ, Van Mark EA, De Maeyer MH, Pelckmans PA, Van Maercke YM. Amoxycillin/clavulanic acid induced cholestasis. J Hepatol 1990; 11:392.
4. 4 Reddy RK, Brillant P, Schiff ER. Amoxycillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989; 96:1135-1141.
5. 5 Smith PM, Wilton A, Routledge PA. Jaundice associated with amoxycillin-clavulanate potassium therapy. Eur J Gastroenterol Hepatol 1991; 3:95-96.
6. 6 Dowsett JF, Gillow T, Haegerty A, Radcliffe M, Toadi R, Isle I, et al. Amoxycillin-clavulanic acid (Augmentin) induced intrahepatic cholestasis. Dig Dis Sci 1989; 34:1290-1293.
7. 7 Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, et al. Hepatitis associated with amoxycillin-clavulanic acid combination: report of 15 cases. Gut 1992; 33:368-371.
8. 8 Wong FS, Ryan J, Dabkowski P, Dudley FJ, Sewell RB, Smallwood RA. Augmentin-induced jaundice. Med J Aust 1991; 154:698-701.
9. 9 Verhamme M, Ramboer C, Van De Bruane P, Inderadjaja N. Cholestatic hepatitis due to an amoxycillin-clavulanate acid preparation. J Hepatol 1989; 9:260-264.
10. 10 Pelletier G, Ink O, Fabre M, Hagège H. Hépatite cholestatique probablement due à l'association d'amoxycilline et d'acid clavulanique. Gastroenterol Clin Biol 1990; 14:601-602.
11. 11 Alexander P, Roskams T, Van Steenbergen W, Peetermans N, Desmet Y, Yap SH. Intrahepatic cholestasis induced by amoxycillin/clavulanic acid (Augmentin): a report on two cases. Acta Clin Belg 1991; 46:327-332.
12. 12 Hantekeet M, Brenard R, Horsmans V, Henrion J, Verbist L, Derue G, et al. Liver injury related to amoxycillin-clavulanic acid: interfobular bile-duct lesion and extrahepatic manifestations. J Hepatol 1995; 22:71-77.
13. 13 Hebbard GS, Smith KGC, Gibson PR, Bhathal PS. Augmentin-induced jaundice with fatal outcome. Med J Aust 1992; 156:285-286.
14. 14 Osuga T, Tanaka N, Matsuzaki Y, Aikawa T. Effects of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis. Dig Dis Sci 1989; 34 (suppl):49-51.
15. 15 Poupon RE, Eschwege E, Poupon R, UDCA-PBC Study Group. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis: interim analysis of a double-blind multicentre randomised trial. J Hepatol 1990; 11:16-21.
16. 16 Beuers U, Spengler U, Kruis W, Aydemir U, Wiebeck B, Heldwein W, et al. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatohgy 1992; 16:707-714.
17. 17 Fried RH, Murakami CS, Fisher MD, Wilsson RA, Sullivan KM, McDonald GB. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host diseases. Ann Intern Med 1992; 116:624-629.
18. 18 Palma J, Reys H, Rbalta J, Iglesias J, Gonzalez M. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15:1043-1047.
19. 19 Kallinowski B, Theilmann L, Zimmermann R, Gams E, Kommerell B, Stiehl A. Effective treatment of cyclosporin-induced cholestasis in heart transplant recipients treated with ursodeoxycholic acid. Transplantation 1991; 51:1128-1129.
20. 20 Piotrowicz A, Polkey M, Wilkinson M. Ursodeoxycholic acid for the treatment of flucloxacillin associated cholestasis. J Hepatol 1995; 22:119-120.
21. 21 Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment of home parenteral-nutrition associated cholestasis. Gastroenterology 1991; 101:250-253.
22. 22 Crosignani A, Podda M, Bertolini E, Battezzate PM, Zuin M, Setchell KDR. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology 1991; 13:1076-1083.
23. 23 Maggiore G, de Giacomo C. Efficacy of ursodeoxycholic acid in preventing cholestatic episodes in a patient with benign recurrent intrahepatic cholestasis [Letter]. Hepatology 1992; 16:504.
24. 24 Hoffman AF. Bile acid hepatotoxicity and the rationale for UDCA therapy in chronic cholestatic liver disease: some hypotheses. In: Strategies for the Treatment of Hepatobiliary Diseases. Paumgartner G, Stiehl A, Barbara L, Roda E (editors). Dordrecht, The Netherlands: Kluwer Academic; 1990. pp. 13-33.
25. 25 Dummont M, Erhinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980; 79:82-89.
26. + replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion. Am J Physiol 1987; 52:G163-G169.
27. 27 Erlinger S. Hypercholeretic bile acids: a clue to mechanism? Hepatology 1990; 11:888-890.
28. 28 Leuschner U, Fischer H, Kurtz W, Guldatuna S, Hubner K, Hellstern A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled, double-blind trial. Gastroenterology 1989; 97:1268-1274.
29. 29 Stiehl A, Raedsch R, Rudolph G. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 1990; 98:424-428.
30. 30 Marteau P, Chazouilleres O, Myara A, Jian R, Rambaund JC, Poupon R. Effects of chronic administration of ursodeoxycholic acid on ileal absorption of endogenous bile acids in man. Hepatology 1990; 12:1206-1208.
31. 31 Schmucker DL, Ohta M, Kanai S, Sata Y, Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990; 12:1216-1221.
32. 32 Heuman DM, Mills AS, McCall J, Hyleman PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology 1991; 100:203-211.
33. 33 Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR. Conjugates of ursodeoxycholic acid protect human red blood cells in vitro against membrane-disrupting effects of more hydrophobic bile salts [Abstract]. Hepatology 1989; 10:728.